Pictet Asset Management
IART icon

Pictet Asset Management’s Integra LifeSciences IART Stock Holding History

Pictet Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$200K Buy
+11,125
New +$156K ﹤0.01% 2001
2024
Q3 		– Sell
-8,311
Closed -$242K – 2030
2024
Q2 		$242K Sell
8,311
-400
-5% -$11.9K ﹤0.01% 1655
2024
Q1 		$309K Sell
8,711
-278
-3% -$11.1K ﹤0.01% 1526
2023
Q4 		$391K Hold
8,989
– – ﹤0.01% 1385
2023
Q3 		$343K Buy
+8,989
New +$378K ﹤0.01% 1401

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Pictet Asset Management's IART Position: Q2 2026 in Review

Pictet Asset Management opened a new position in Integra LifeSciences (IART) in Q2 2026: 11,125 shares worth $200K. The stake represents ﹤0.01% of the portfolio and ranks #2001 among its holdings. This is a return to the name: Pictet Asset Management previously reported a position in IART as recently as Q2 2024.

Pictet Asset Management first reported a position in IART in Q3 2023 and has held it in 5 quarters since. The position peaked at $391K in Q4 2023. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Pictet Asset Management held 11,125 shares of Integra LifeSciences worth $200K as of Q2 2026.
  • Integra LifeSciences was a new Pictet Asset Management position in Q2 2026.
  • Integra LifeSciences made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #2001 holding.
  • Pictet Asset Management first reported a position in Integra LifeSciences in Q3 2023 and has held it in 5 quarters since.
  • Pictet Asset Management's Integra LifeSciences position peaked at $391K in Q4 2023.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.